chrX-151740867-C-A

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_005140.3(CNGA2):​c.448C>A​(p.Pro150Thr) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 23)

Consequence

CNGA2
NM_005140.3 missense

Scores

2
13
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.10
Variant links:
Genes affected
CNGA2 (HGNC:2149): (cyclic nucleotide gated channel subunit alpha 2) The protein encoded by this gene represents the alpha subunit of a cyclic nucleotide-gated olfactory channel. The encoded protein contains a carboxy-terminal leucine zipper that mediates channel formation. [provided by RefSeq, Jan 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CNGA2NM_005140.3 linkc.448C>A p.Pro150Thr missense_variant 5/7 ENST00000329903.5 NP_005131.1 Q16280B3KXY3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CNGA2ENST00000329903.5 linkc.448C>A p.Pro150Thr missense_variant 5/75 NM_005140.3 ENSP00000328478.4 Q16280

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
23

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 08, 2023The c.448C>A (p.P150T) alteration is located in exon 5 (coding exon 4) of the CNGA2 gene. This alteration results from a C to A substitution at nucleotide position 448, causing the proline (P) at amino acid position 150 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.36
BayesDel_addAF
Uncertain
0.13
D
BayesDel_noAF
Uncertain
-0.050
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.75
D
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Uncertain
0.95
D
M_CAP
Uncertain
0.18
D
MetaRNN
Uncertain
0.63
D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Uncertain
2.2
M
PrimateAI
Uncertain
0.62
T
PROVEAN
Pathogenic
-5.0
D
REVEL
Uncertain
0.55
Sift
Benign
0.056
T
Sift4G
Uncertain
0.048
D
Polyphen
0.80
P
Vest4
0.40
MutPred
0.61
Gain of glycosylation at P150 (P = 0.0983);
MVP
0.99
MPC
0.075
ClinPred
0.98
D
GERP RS
5.4
Varity_R
0.65
gMVP
0.67

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chrX-150909339; API